IMARC examined the warning letters posted on the FDA’s website to compile the top findings from BIMO inspections. This year, we are reflecting on the top findings of previous years and discussing trends seen in 2018.
Are there improvements your study team can attain to avoid these year-to-year trending deficiencies?